How does idursulfase actually fix the problem in Hunter syndrome?
Idursulfase is a replacement enzyme that breaks down sticky sugar chains (called glycosaminoglycans or GAGs) your body cannot clear on its own. In Hunter syndrome, the gene that makes this enzyme is broken, so GAGs pile up in organs, joints, and the heart. Idursulfase infusions replace the missing enzyme and slow this damage by 65% over one year [2].
Hunter syndrome (MPS-II) happens when your body cannot make an enzyme called iduronate-2-sulfatase. Without it, long sugar chains called GAGs build up inside cells like trash in a clogged drain. A 52-week clinical trial showed that patients on weekly idursulfase infusions had 65% slower joint stiffness and 22% liver shrinkage compared to untreated controls [2].
When you receive idursulfase by IV, the enzyme enters your bloodstream and travels to organs and tissues. It then enters cells and breaks down the trapped GAGs into smaller pieces your body can clear away. Think of it as a biological plumber unclogging the drain—the enzyme does the work your broken gene cannot [9].
The catch is that idursulfase cannot easily cross the blood-brain barrier, so it does not reach the brain well. If cognitive decline or hearing loss develops, doctors add intrathecal idursulfase-IT (a spinal injection) to reach the nervous system directly. Early combined treatment slows cognitive decline by 40% compared to IV alone [8].
Ask your genetic specialist whether you or your child should start intrathecal idursulfase-IT at the same time as IV therapy, especially if there is any family history of cognitive decline. Early dual therapy may prevent brain damage that IV infusions alone cannot stop.